Skip to main content

Market Overview

Biogen To Build New Gene Therapy Facility With $200M Investment

  • Biogen Inc (NASDAQ: BIIBplans to build a new gene therapy manufacturing facility at its Research Triangle Park manufacturing campuses in North Carolina to support its growing gene therapy pipeline, with an estimated total investment of approximately $200 million.
  • Biogen aims to continue its investment in North Carolina through the new facility and expand its existing operations and a combined workforce of approximately 1,900 employees at both campuses in Research Triangle Park.
  • The new 175,000 square feet facility will create approximately 90 new jobs and be operational by 2023.
  • Price Action: BIIB shares are up 0.3% at $267.33 in market trading hours on the last check Thursday.

Related Articles (BIIB)

View Comments and Join the Discussion!

Posted-In: Biotech News Health Care FDA General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at